Isoprostanes and neuroprostanes: Total synthesis, biological activity and biomarkers of oxidative stress in humans

Prostaglandins and Other Lipid Mediators

Volumn 107, Issue , 2013, Pages 95-102

  Galano, Jean Marie ^a   Mas, Emilie ^b   Barden, Anne ^b   Mori, Trevor A ^b   Signorini, Cinzia ^c   De Felice, Claudio ^d   Barrett, Aaron ^e   Opere, Catherine ^e   Pinot, Edith ^a   Schwedhelm, Edzard ^f   Benndorf, Ralf ^h   Roy, Jérôme ^g   Le Guennec, Jean Yves ^g   Oger, Camille ^a   Durand, Thierry ^a  

^a UNIVERSITÉ DE MONTPELLIER   (France)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF SIENA   (Italy)

^d UNIVERSITY HOSPITAL OF SIENA   (Italy)

^e CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^g INSERM   (France)

^h UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Bioactive lipids; Biomarkers; Isoprostanes; Metabolites; Neuroprostanes; PUFAs

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; FISH OIL; ISOPROSTANE DERIVATIVE; METHYL CPG BINDING PROTEIN 2; NEUROPROSTANE; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F2; THROMBOXANE RECEPTOR;

ANESTHESIA; ANTIARRHYTHMIC ACTIVITY; BIOLOGICAL ACTIVITY; BRAIN INJURY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIPID PEROXIDATION; LIPOGENESIS; NEUROTRANSMITTER RELEASE; NONHUMAN; OXIDATIVE STRESS; OXYGEN CONCENTRATION; OXYGEN TENSION; PEROXIDATION; PREECLAMPSIA; REPERFUSION INJURY; RETT SYNDROME; REVIEW; SUPPLEMENTATION; SYNTHESIS; VASCULAR TISSUE;

BIOACTIVE LIPIDS; BIOMARKERS; ISOPROSTANES; METABOLITES; NEUROPROSTANES; PUFAS;

ANIMALS; BIOLOGICAL MARKERS; FATTY ACIDS, OMEGA-3; HEMODYNAMICS; HUMANS; ISOPROSTANES; LIPID PEROXIDATION; NEUROPROSTANES; OXIDATIVE STRESS; REPERFUSION INJURY;

EID: 84889102599     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2013.04.003     Document Type: Review

References (91)

1. B.G. Halliwell Free radical in biology and medicine 3rd ed. 1999 Oxford University Press New York
2. U. Jahn, J.M. Galano, and T. Durand Beyond prostaglandins-chemistry and biology of cyclic oxygenated metabolites formed by free-radical pathways from polyunsaturated fatty acids Angew Chem Int Ed Engl 47 32 2008 5894 5955
3. J.D. Morrow, K.E. Hill, R.F. Burk, T.M. Nammour, K.F. Badr, and L.J. Roberts II A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism Proc Natl Acad Sci USA 87 23 1990 9383 9387 (Pubitemid 120030630)
4. D. Tsikas, M.T. Suchy, and J. Niemann Glutathione promotes prostaglandin H synthase (cyclooxygenase)-dependent formation of malondialdehyde and 15(S)-8-iso-prostaglandin F2alpha FEBS Lett 586 20 2012 3723 3730
5. M.B. Kadiiska, B.C. Gladen, and D.D. Baird Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med 38 6 2005 698 710 (Pubitemid 40249740)
6. G.L. Milne, H. Yin, K.D. Hardy, S.S. Davies, and L.J. Roberts II Isoprostane generation and function Chem Rev 111 10 2011 5973 5996
7. A.E. Barden, K.D. Croft, T. Durand, A. Guy, M.J. Mueller, and T.A. Mori Flaxseed oil supplementation increases plasma F1-phytoprostanes in healthy men J Nutr 139 10 2009 1890 1895
8. A. Barden, E. Mas, and P. Henry The effects of oxidation products of arachidonic acid and n3 fatty acids on vascular and platelet function Free Radic Res 45 4 2011 469 476
9. J. Nourooz-Zadeh, E.H. Liu, E. Anggard, and B. Halliwell F4-isoprostanes: a novel class of prostanoids formed during peroxidation of docosahexaenoic acid (DHA) Biochem Biophys Res Commun 242 2 1998 338 344 (Pubitemid 28412429)
10. M. VanRollins, R.L. Woltjer, H. Yin, J.D. Morrow, and T.J. Montine F2-dihomo-isoprostanes arise from free radical attack on adrenic acid J Lipid Res 49 5 2008 995 1005
11. J.P. Fessel, and L. Jackson Roberts Isofurans: novel products of lipid peroxidation that define the occurrence of oxidant injury in settings of elevated oxygen tension Antioxid Redox Signal 7 1-2 2005 202 209 (Pubitemid 40187937)
12. J.P. Fessel, N.A. Porter, K.P. Moore, J.R. Sheller, and L.J. Roberts II Discovery of lipid peroxidation products formed in vivo with a substituted tetrahydrofuran ring (isofurans) that are favored by increased oxygen tension Proc Natl Acad Sci USA 99 26 2002 16713 16718 (Pubitemid 36034038)
13. N.A. Porter, and M.O. Funk Letter: peroxy radical cyclization as a model for prostaglandin biosynthesis J Org Chem 40 24 1975 3614 3615
14. W.A. Pryor, and J.P. Stanley Letter: a suggested mechanism for the production of malonaldehyde during the autoxidation of polyunsaturated fatty acids. Nonenzymatic production of prostaglandin endoperoxides during autoxidation J Org Chem 40 24 1975 3615 3617
15. J.D. Morrow, J.A. Awad, H.J. Boss, I.A. Blair, and L.J. Roberts II Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids Proc Natl Acad Sci USA 89 22 1992 10721 10725
16. N. Kono, T. Inoue, and Y. Yoshida Protection against oxidative stress-induced hepatic injury by intracellular type II platelet-activating factor acetylhydrolase by metabolism of oxidized phospholipids in vivo J Biol Chem 283 3 2008 1628 1636
17. D.M. Stafforini, J.R. Sheller, and T.S. Blackwell Release of free F2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases J Biol Chem 281 8 2006 4616 4623 (Pubitemid 43847720)
18. J.M. Proudfoot, A.E. Barden, W.M. Loke, K.D. Croft, I.B. Puddey, and T.A. Mori HDL is the major lipoprotein carrier of plasma F2-isoprostanes J Lipid Res 50 4 2009 716 722
19. Z. Yan, E. Mas, T.A. Mori, K.D. Croft, and A.E. Barden A significant proportion of F2-isoprostanes in human urine are excreted as glucuronide conjugates Anal Biochem 403 1-2 2010 126 128
20. N. Kornblum, and H.E. DeLaMare The base catalyzed decomposition of a dialkyl peroxide J Am Chem Soc 73 1951 880 881
21. R.J. Waugh, J.D. Morrow, L.J. Roberts II, and R.C. Murphy Identification and relative quantitation of F2-isoprostane regioisomers formed in vivo in the rat Free Radic Biol Med 23 6 1997 943 954 (Pubitemid 27402620)
22. H. Li, J.A. Lawson, and M. Reilly Quantitative high performance liquid chromatography/tandem mass spectrometric analysis of the four classes of F(2)-isoprostanes in human urine Proc Natl Acad Sci USA 96 23 1999 13381 13386
23. H. Yin, J.D. Morrow, and N.A. Porter Identification of a novel class of endoperoxides from arachidonate autoxidation J Biol Chem 279 5 2004 3766 3776 (Pubitemid 38140621)
24. H. Yin, E.S. Musiek, L. Gao, N.A. Porter, and J.D. Morrow Regiochemistry of neuroprostanes generated from the peroxidation of docosahexaenoic acid in vitro and in vivo J Biol Chem 280 28 2005 26600 26611 (Pubitemid 41022258)
25. A. Roland, T. Durand, B. Rondot, J.-P. Vidal, and J.-C. Rossi A practical asymmetric synthesis of ent-12-epi-PGF-2.alpha. methyl ester Bull Soc Chim Fr 133 1996 1149 1154 (Pubitemid 126764897)
26. E. Pinot, A. Guy, A. Fournial, L. Balas, J.C. Rossi, and T. Durand Total synthesis of the four enantiomerically pure diasteroisomers of the phytoprostanes E1Type II and of the 15-E2t-isoprostanes J Org Chem 73 8 2008 3063 3069 (Pubitemid 351543956)
27. C. Oger, Y. Brinkmann, S. Bouazzaoui, T. Durand, and J.M. Galano Stereocontrolled access to isoprostanes via a bicyclo[3.3.0]octene framework Org Lett 10 21 2008 5087 5090
28. C. Oger, Z. Marton, and Y. Brinkmann Lipase-catalyzed regioselective monoacetylation of unsymmetrical 1,5-primary diols J Org Chem 75 6 2010 1892 1897
29. Y. Brinkmann, C. Oger, A. Guy, T. Durand, and J.M. Galano Total synthesis of 15-D(2t)-and 15-epi-15-E(2t)-isoprostanes J Org Chem 75 7 2010 2411 2414
30. C. Oger, V. Bultel-Ponce, and A. Guy The handy use of Brown's P2-Ni catalyst for a skipped diyne deuteration: application to the synthesis of a [D4]-labeled F4t-neuroprostane Chemistry 16 47 2010 13976 13980
31. C. Oger, V. Bultel-Poncé, A. Guy, T. Durand, and J.M. Galano Total synthesis of isoprostanes derived from adrenic acid and EPA Eur J Org Chem 13 2012 2621 2634
32. S.S. Davies, and L.J. Roberts II F2-isoprostanes as an indicator and risk factor for coronary heart disease Free Radic Biol Med 50 5 2011 559 566
33. S. Basu F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications Antioxid Redox Signal 10 8 2008 1405 1434
34. J.D. Morrow, J.A. Awad, and T. Kato Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation J Clin Invest 90 6 1992 2502 2507 (Pubitemid 23010071)
35. D. Pratico, J.A. Lawson, and G.A. FitzGerald Cyclooxygenase-dependent formation of the isoprostane, 8-epi prostaglandin F2 alpha J Biol Chem 270 17 1995 9800 9808
36. B.F. McAdam, I.A. Mardini, and A. Habib Effect of regulated expression of human cyclooxygenase isoforms on eicosanoid and isoeicosanoid production in inflammation J Clin Invest 105 10 2000 1473 1482 (Pubitemid 30322413)
37. A. Bachi, R. Brambilla, R. Fanelli, R. Bianchi, E. Zuccato, and C. Chiabrando Reduction of urinary 8-epi-prostaglandin F2 alpha during cyclo-oxygenase inhibition in rats but not in man Br J Pharmacol 121 8 1997 1770 1774 (Pubitemid 27343409)
38. L. Sautebin, A. Ianaro, L. Rombola, A. Ialenti, A. Sala, and M. Di Rosa Cyclooxygenase-2-dependent generation of 8-epiprostaglandin F2alpha by lipopolysaccharide-activated J774 macrophages Inflamm Res 48 9 1999 503 508 (Pubitemid 29450249)
39. K.B. Jourdan, T.W. Evans, P. Goldstraw, and J.A. Mitchell Isoprostanes and PGE2 production in human isolated pulmonary artery smooth muscle cells: concomitant and differential release FASEB J 13 9 1999 1025 1030 (Pubitemid 29249727)
40. H. Bayir, V.E. Kagan, and Y.Y. Tyurina Assessment of antioxidant reserves and oxidative stress in cerebrospinal fluid after severe traumatic brain injury in infants and children Pediatr Res 51 5 2002 571 578 (Pubitemid 34453572)
41. A.K. Wagner, H. Bayir, D. Ren, A. Puccio, R.D. Zafonte, and P.M. Kochanek Relationships between cerebrospinal fluid markers of excitotoxicity, ischemia, and oxidative damage after severe TBI: the impact of gender, age, and hypothermia J Neurotrauma 21 2 2004 125 136 (Pubitemid 38233843)
42. J. Proudfoot, A. Barden, and T.A. Mori Measurement of urinary F(2)-isoprostanes as markers of in vivo lipid peroxidation-a comparison of enzyme immunoassay with gas chromatography/mass spectrometry Anal Biochem 272 2 1999 209 215 (Pubitemid 29364984)
43. A. Rodgers, N. Walker, and S. Schug Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials BMJ 321 7275 2000 1493
44. E. Mas, A.E. Barden, T.B. Corcoran, M. Phillips, L.J. Roberts II, and T.A. Mori Effects of spinal or general anesthesia on F(2)-isoprostanes and isofurans during ischemia/reperfusion of the leg in patients undergoing knee replacement surgery Free Radic Biol Med 50 9 2011 1171 1176
45. T.B. Corcoran, A.E. Barden, and E. Mas Hemoglobin attenuates the effects of inspired oxygen on plasma isofurans in humans during upper-limb surgery Free Radic Biol Med 51 6 2011 1235 1239
46. L.J. Roberts II, J.P. Fessel, and S.S. Davies The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation Brain Pathol 15 2 2005 143 148 (Pubitemid 40546170)
47. T.B. Corcoran, E. Mas, and A.E. Barden Are isofurans and neuroprostanes increased after subarachnoid hemorrhage and traumatic brain injury? Antioxid Redox Signal 15 10 2011 2663 2667
48. Y.P. Hsieh, C.L. Lin, and A.L. Shiue Correlation of F4-neuroprostanes levels in cerebrospinal fluid with outcome of aneurysmal subarachnoid hemorrhage in humans Free Radic Biol Med 47 6 2009 814 824
49. S.E. Farias, M. Basselin, L. Chang, K.A. Heidenreich, S.I. Rapoport, and R.C. Murphy Formation of eicosanoids, E2/D2 isoprostanes, and docosanoids following decapitation-induced ischemia, measured in high-energy-microwaved rat brain J Lipid Res 49 9 2008 1990 2000
50. A. Barden, L.J. Beilin, J. Ritchie, K.D. Croft, B.N. Walters, and C.A. Michael Plasma and urinary 8-iso-prostane as an indicator of lipid peroxidation in pre-eclampsia and normal pregnancy Clin Sci (Lond) 91 6 1996 711 718 (Pubitemid 26413825)
51. A.E. Barden, T.B. Corcoran, and E. Mas Is there a role for isofurans and neuroprostanes in pre-eclampsia and normal pregnancy? Antioxid Redox Signal 16 2 2012 165 169
52. E. Mas, R.J. Woodman, and V. Burke The omega-3 fatty acids EPA and DHA decrease plasma F(2)-isoprostanes: results from two placebo-controlled interventions Free Radic Res 44 9 2010 983 990
53. T.A. Mori, R.J. Woodman, V. Burke, I.B. Puddey, K.D. Croft, and L.J. Beilin Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects Free Radic Biol Med 35 7 2003 772 781 (Pubitemid 37329480)
54. R.E. Amir, I.B. Van den Veyver, M. Wan, C.Q. Tran, U. Francke, and H.Y. Zoghbi Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 Nat Genet 23 2 1999 185 188 (Pubitemid 29455390)
55. J. Christodoulou, A. Grimm, T. Maher, and B. Bennetts RettBASE: the IRSA MECP2 variation database-a new mutation database in evolution Hum Mutat 21 5 2003 466 472
56. J.L. Neul, W.E. Kaufmann, and D.G. Glaze Rett syndrome: revised diagnostic criteria and nomenclature Ann Neurol 68 6 2010 944 950
57. S. Leoncini, C. De Felice, and C. Signorini Oxidative stress in Rett syndrome: natural history, genotype, and variants Redox Rep 16 4 2011 145 153
58. P.S. Sastry Lipids of nervous tissue: composition and metabolism Prog Lipid Res 24 1985 69 176
59. C. De Felice, C. Signorini, and T. Durand F2-dihomo-isoprostanes as potential early biomarkers of lipid oxidative damage in Rett syndrome J Lipid Res 52 12 2011 2287 2297
60. A. Mahmood, G. Bibat, and A.L. Zhan White matter impairment in Rett syndrome: diffusion tensor imaging study with clinical correlations AJNR Am J Neuroradiol 31 2 2010 295 299
61. C. Signorini, C. De Felice, and S. Leoncini F(4)-neuroprostanes mediate neurological severity in Rett syndrome Clin Chim Acta 412 15-16 2011 1399 1406
62. J.L. Cracowski, and T. Durand Cardiovascular pharmacology and physiology of the isoprostanes Fundam Clin Pharmacol 20 5 2006 417 427 (Pubitemid 44393957)
63. H.J. Ting, and F.T. Khasawneh Platelet function and isoprostane biology. Should isoprostanes be the newest member of the orphan-ligand family? J Biomed Sci 17 1 2010 p24
64. A. Kumar, E. Kingdon, and J. Norman The isoprostane 8-iso-PGF2alpha suppresses monocyte adhesion to human microvascular endothelial cells via two independent mechanisms FASEB J 19 3 2005 443 445 (Pubitemid 40316544)
65. N. Leitinger, J. Huber, and C. Rizza The isoprostane 8-iso-PGF(2alpha) stimulates endothelial cells to bind monocytes: differences from thromboxane-mediated endothelial activation FASEB J 15 7 2001 1254 1256
66. S.M. Miggin, and B.T. Kinsella Thromboxane A(2) receptor mediated activation of the mitogen activated protein kinase cascades in human uterine smooth muscle cells Biochim Biophys Acta 1539 1-2 2001 147 162 (Pubitemid 32522877)
67. T. Yura, M. Fukunaga, R. Khan, G.N. Nassar, K.F. Badr, and A. Montero Free-radical-generated F2-isoprostane stimulates cell proliferation and endothelin-1 expression on endothelial cells Kidney Int 56 2 1999 471 478 (Pubitemid 29353144)
68. C. Cossette, S.E. Walsh, and S. Kim Agonist and antagonist effects of 15R-prostaglandin (PG) D2 and 11-methylene-PGD2 on human eosinophils and basophils J Pharmacol Exp Ther 320 1 2007 173 179 (Pubitemid 46025732)
69. J.L. Cracowski, F. Stanke-Labesque, and P. Devillier Human internal mammary artery contraction by isoprostaglandin f(2alpha) type-III [8-iso-prostaglandin F(2alpha)] Eur J Pharmacol 397 1 2000 161 168 (Pubitemid 30323822)
70. L.J. Janssen, and T. Tazzeo Involvement of TP and EP3 receptors in vasoconstrictor responses to isoprostanes in pulmonary vasculature J Pharmacol Exp Ther 301 3 2002 1060 1066 (Pubitemid 34595098)
71. P. Kunapuli, J.A. Lawson, J. Rokach, and G.A. FitzGerald Functional characterization of the ocular prostaglandin f2alpha (PGF2alpha) receptor. Activation by the isoprostane, 12-iso-PGF2alpha J Biol Chem 272 43 1997 27147 27154 (Pubitemid 27452672)
72. E.S. Musiek, L. Gao, and G.L. Milne Cyclopentenone isoprostanes inhibit the inflammatory response in macrophages J Biol Chem 280 42 2005 35562 35570 (Pubitemid 41532748)
73. F.M. Daray, J.R. Colombo, and J.R. Kibrik Involvement of endothelial thromboxane A2 in the vasoconstrictor response induced by 15-E2t-isoprostane in isolated human umbilical vein Naunyn Schmiedebergs Arch Pharmacol 373 5 2006 367 375 (Pubitemid 44215583)
74. A.M. Friel, P.G. Hynes, D.J. Sexton, T.J. Smith, and J.J. Morrison Expression levels of mRNA for Rho A/Rho kinase and its role in isoprostane-induced vasoconstriction of human placental and maternal vessels Reprod Sci 15 2 2008 179 188 (Pubitemid 351903530)
75. L.J. Janssen, M. Premji, S. Netherton, J. Coruzzi, H. Lu-Chao, and P.G. Cox Vasoconstrictor actions of isoprostanes via tyrosine kinase and Rho kinase in human and canine pulmonary vascular smooth muscles Br J Pharmacol 132 1 2001 127 134 (Pubitemid 32128441)
76. I. Mueed, T. Tazzeo, and C. Liu Isoprostanes constrict human radial artery by stimulation of thromboxane receptors, Ca2+ release, and RhoA activation J Thorac Cardiovasc Surg 135 1 2008 131 138
77. S. Simonet, E. Bonhomme, J.N. Fabiani, and T. Verbeuren Temperature-dependent basal tone in isolated human saphenous veins: implication of TP-receptors Fundam Clin Pharmacol 14 5 2000 461 467
78. T. Tazzeo, J. Miller, and L.J. Janssen Vasoconstrictor responses, and underlying mechanisms, to isoprostanes in human and porcine bronchial arterial smooth muscle Br J Pharmacol 140 4 2003 759 763 (Pubitemid 37386441)
79. S. Marliere, J.L. Cracowski, and T. Durand The 5-series F(2)-isoprostanes possess no vasomotor effects in the rat thoracic aorta, the human internal mammary artery and the human saphenous vein Br J Pharmacol 135 5 2002 1276 1280 (Pubitemid 34259130)
80. K. Greaves, S.R. Dixon, and I.O. Coker Influence of isoprostane F2alpha-III on reflow after myocardial infarction Eur Heart J 25 10 2004 847 853 (Pubitemid 38679943)
81. R.A. Benndorf, E. Schwedhelm, and A. Gnann Isoprostanes inhibit vascular endothelial growth factor-induced endothelial cell migration, tube formation, and cardiac vessel sprouting in vitro, as well as angiogenesis in vivo via activation of the thromboxane A(2) receptor: a potential link between oxidative stress and impaired angiogenesis Circ Res 103 9 2008 1037 1046
82. M. Tanito, R.S. Brush, M.H. Elliott, L.D. Wicker, K.R. Henry, and R.E. Anderson High levels of retinal membrane docosahexaenoic acid increase susceptibility to stress-induced degeneration J Lipid Res 50 5 2009 807 819
83. A. Izzotti, A. Bagnis, and S.C. Sacca The role of oxidative stress in glaucoma Mutat Res 612 2 2006 105 114 (Pubitemid 43222096)
84. C.A. Opere, K. Ford, M. Zhao, and S.E. Ohia Regulation of neurotransmitter release from ocular tissues by isoprostanes Methods Find Exp Clin Pharmacol 30 9 2008 697 701
85. J. Jamil, A. Wright, and N. Harrison Regulation of [(3)H]d-aspartate release by the 5-F(2t)-isoprostane and its 5-epimer in isolated bovine retina Neurochem Res 37 3 2012 574 582
86. D. Mozaffarian, and J.H.Y. Wu Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events J Am Coll Cardiol 58 20 2011 2047 2067
87. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin, E, after myocardial infarction: results of the GISSI-Prevenzione, trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto, miocardico Lancet 354 9177 1999 447 455
88. P. Saravanan, N.C. Davidson, E.B. Schmidt, and P.C. Calder Cardiovascular effects of marine omega-3 fatty acids Lancet 376 9740 2010 540 550
89. S. Judé, S. Roger, and E. Martel Dietary long-chain omega-3 fatty acids of marine origin: a comparison of their protective effects on coronary heart disease and breast cancers Prog Biophys Mol Biol 90 1-3 2006 299 325 (Pubitemid 41721056)
90. S. Jude, S. Bedut, and S. Roger Peroxidation of docosahexaenoic acid is responsible for its effects on I TO and I SS in rat ventricular myocytes Br J Pharmacol 139 4 2003 816 822 (Pubitemid 36819609)
91. Le Guennec JY, Galano JM, Oger C, Thireau J, Roy J, Bultel-Poncé V, Guy A, Durand T, Methods and pharmaceutical composition for the treatment and prevention of cardiac arrhythmias European patent 5-EP12306519.3, December 2012.